Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Committee will help advise on research and innovation in the whole-of-government response to the longer-term impacts of COVID-19.
The COVID virus infected coronary arteries and increased inflammation in atherosclerotic plaques.
Study findings shed light on possible causes of long COVID and could lead to more sensitive testing and personalized treatments.
Study findings identify a potential marker that could help identify people at high risk of developing long COVID.
Updated coronavirus vaccine is recommended for all adults and children ages 6 months and older.
NIH-funded research links alterations to inflammatory protein, underscores vaccine importance.
Current analysis estimates that 7.7 million to 23 million Americans have developed long COVID.
The first studies, launched on July 31, will focus on viral persistence and cognitive dysfunction.
Clarifying symptoms may help guide clinical trials to develop treatments for postacute sequelae of SARS-CoV-2.
The compromise bill leaves Medicare and Medicaid funding untouched and includes no new work requirements for Medicaid.
Research identifies most common symptoms and potential subgroups with the aim of improving future diagnostics and treatment.
Study suggests adults with both the sleep disorder and COVID-19 may benefit from clinical monitoring.
Findings from NIH study offer insight into biological mechanisms, pointing to possible treatments.
Many people experiencing lingering effects of the virus say they feel angry and abandoned by policymakers eager to move on.
Fatigue, a common companion of many chronic illnesses, is a persistent feeling of having no energy, even with minimal or no exertion.
Herpes, HIV, Epstein-Barr and other viruses hang around, causing potential long-term health woes. Should long COVID surprise us?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.